Acadia Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Acadia Pharmaceuticals Inc
CIK #0001070494
EDGAR Form CIK 2011 - 2025
10-K [0001070494]
10-Q [0001070494]
3 [0001070494]
4 [0001070494]
8-K [0001070494]
D [0001070494]
SC 13D [0001070494]
SC 13G [0001070494]
Form 13D/13G Filer Form 13D/13G Subject Filed
RTW Investments LP Acadia Pharmaceuticals Inc [2024-02-14]
Price T Rowe Associates Inc /MD/ Acadia Pharmaceuticals Inc [2022-02-14]
BlackRock Inc Acadia Pharmaceuticals Inc [2022-02-04]
Price T Rowe Associates Inc /MD/ Acadia Pharmaceuticals Inc [2020-02-14]
Point72 Asset Management LP Acadia Pharmaceuticals Inc [2018-06-18]
Janus Henderson Group PLC Acadia Pharmaceuticals Inc [2018-02-12]
BlackRock Inc Acadia Pharmaceuticals Inc [2018-02-01]
Vanguard Group Inc Acadia Pharmaceuticals Inc [2016-02-10]
Price T Rowe Associates Inc /MD/ Acadia Pharmaceuticals Inc [2015-02-12]
Viking Global Investors LP Acadia Pharmaceuticals Inc [2014-05-05]
BlackRock Inc Acadia Pharmaceuticals Inc [2014-01-28]
Baker Bros Advisors LLC Acadia Pharmaceuticals Inc [2012-12-21]
Visium Asset Management LP Acadia Pharmaceuticals Inc [2012-12-21]
Venrock Healthcare Capital Partners LP Acadia Pharmaceuticals Inc [2012-02-14]
Form 3/4/5 Subject 2011 - 2025
Acadia Pharmaceuticals Inc
Schneyer Mark C.
Brege Laura
Daly James M
Garofalo Elizabeth A
Baker Bros. Advisors (GP) LLC
Baker Bros Advisors LP
667 LP
Baker Felix
Baker Brothers Life Sciences LP
View All
Terms | Privacy | Guide
tony@aum13f.com